Ballicules.com

Chlorpheniramine

CHLOR-TRIMETON

What it isFirst-generation H1 antagonist; allergic rhinitis and cold remedies.

Why this oneIt is less sedating than diphenhydramine but remains common in multi-ingredient cold products.

What limits itAnticholinergic burden and sedation make it poor for older adults and unsafe before driving.

FDA-approved for

FDA label

FDA dosingPopulationStartTargetMax
Temporary relief of hay fever/upper respiratory allergy symptoms (sneezing, runny nose, itchy watery eyes, itchy nose/throat)Adults & children ≥12 y1 tablet (4 mg) q4–6h PRN1 tablet (4 mg) q4–6h PRN6 tablets (24 mg)/24 h
Temporary relief of hay fever/upper respiratory allergy symptomsChildren 6 to <12 y1/2 tablet (2 mg) q4–6h PRN (break tablet in half)1/2 tablet (2 mg) q4–6h PRN3 whole tablets (12 mg)/24 h

Renal Undefined

Hepatic Undefined

Dose no more often than every 4 to 6 hours; do not exceed the stated 24-hour tablet limit.

Instructions

Contraindications

Cautions

Adverse reactions

Pregnancy If pregnant, ask a health professional before use (OTC drug-facts statement).

Lactation If breast-feeding, ask a health professional before use (OTC drug-facts statement).

NO BOXED WARNINGS

Principal riskAnticholinergic burden and sedation, so it is poor in the elderly

Classes and tags

Clinical profile

Direct muscarinic antagonism1 / 4

Mechanism of action: Chlorpheniramine ballicule

Chlorpheniramine ballicule: receptor binding, kinetics and half-life diagram

Open Chlorpheniramine in the interactive console ↗